Dorian Paul LeBlanc - 10 Mar 2026 Form 4 Insider Report for LEMAITRE VASCULAR INC (LMAT)

Signature
/s/ Laurie A. Churchill, Attorney-in-fact
Issuer symbol
LMAT
Transactions as of
10 Mar 2026
Net transactions value
$0
Form type
4
Filing time
12 Mar 2026, 16:12:03 UTC
Previous filing
11 Dec 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
LeBlanc Dorian Paul Chief Financial Officer C/O LEMAITRE VASCULAR, INC., 63 SECOND AVENUE, BURLINGTON /s/ Laurie A. Churchill, Attorney-in-fact 12 Mar 2026 0002061481

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LMAT Common Stock Options Exercise +2 +0.08% $0.000000* 2,400 10 Mar 2026 Direct F1
transaction LMAT Common Stock Tax liability -96 -4% $109.20* 2,302 10 Mar 2026 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LMAT Dividend Equivalent Rights Options Exercise -2 -18% $0.000000* 9 10 Mar 2026 Common Stock 2 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.
F2 These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on March 10, 2025. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.
F3 These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on March 10, 2025. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.